Loading...

Loading...

Lilly Expands Access to Obesity Medicines Through US Agreement
By MBN Staff - Mon, 11/10/2025 - 11:12
Lilly partners with the US government to expand access to obesity drugs, reinforcing its long-term commitment to healthcare affordability.
https://mexicobusiness.news/tag/fda-approval
More Health
Pfizer to Acquire Metsera to Expand Obesity Portfolio
By Sofía Garduño - Mon, 09/22/2025 - 11:59
Pfizer will acquire Metsera for US$4.9 billion, expanding its pipeline of obesity and cardiometabolic treatments.
FDA Approves Wegovy for Adults with MASH, Liver Fibrosis
By Sofía Garduño - Mon, 08/18/2025 - 09:14
The US FDA approves Wegovy to treat adults with MASH and moderate to advanced liver fibrosis, excluding cirrhosis.
J&J, Medtronic, Novo Nordisk in the Spotlight: The Week in Health
By Sofía Garduño - Thu, 07/24/2025 - 08:59
This week J&J files for psoriasis drug, Medtronic expands device use in the European Union, and Novo Nordisk launches an e-commerce store in Mexico.
Apotex Expands Licensing Deal for Ophthalmic Drug APP13007
By MBN Staff - Tue, 05/13/2025 - 18:08
Apotex extends its deal with Formosa to commercialize the FDA-approved ophthalmic drug APP13007 in Mexico, pending regulatory approval.
Eli Lilly’s Omvoh Shows Long-Term Efficacy in Crohn’s Disease
By MBN Staff - Wed, 02/12/2025 - 17:53
New data from Eli Lilly's VIVID-2 study shows that Omvoh sustains clinical and endoscopic benefits in Crohn’s disease over two years.
FDA Approves Bristol Myers Squibb's Injectable Opdivo
By MBN Staff - Wed, 01/08/2025 - 09:50
FDA approves Bristol Myers Squibb's injectable Opdivo, offering a convenient treatment for cancer patients, expanding options and supporting growth.

Pfizer’s BRAFTOVI Regimen Approved for Metastatic CRC
By MBN Staff - Mon, 12/23/2024 - 13:39
Pfizer's BRAFTOVI, combined with cetuximab and mFOLFOX6, is FDA-approved for treating metastatic colorectal cancer with a BRAF V600E mutation.
FDA Approves UNLOXCYT for Skin Cancer Treatment
By MBN Staff - Fri, 12/20/2024 - 14:50
FDA approves Checkpoint Therapeutics’ UNLOXCYT , a PD-L1 antibody drug offering efficacy in metastatic and locally advanced cases of skin cancer.

FDA Clears Air Assist Device for Enhanced Colonoscopy Efficiency
By MBN Staff - Fri, 12/20/2024 - 14:45
Astro Concepts receives FDA clearance for the Air Assist™ device, a new solution to improve colonoscopy safety and efficiency.